1. Scaling up cancer care for children without medical insurance in developing countries: The case of Mexico
- Author
-
Salomón Chertorivski-Woldenberg, Lindsay Frazier, Svetlana V. Doubova, Onofre Muñoz-Hernández, Ricardo Pérez-Cuevas, Carlos Rodriguez-Galindo, Gabriel Cortés-Gallo, Sergio Flores-Hernández, and Marta Zapata-Tarrés
- Subjects
medicine.medical_specialty ,Pediatrics ,business.industry ,Retinoblastoma ,Hazard ratio ,Cancer ,Myeloid leukemia ,Retrospective cohort study ,Hematology ,Disease ,medicine.disease ,Lymphoma ,Oncology ,hemic and lymphatic diseases ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,business ,Cohort study - Abstract
acute myeloid leukemia (AML, 7.4%). The survival rates at 36 months were ALL (50%), AML (30.5%), Hodgkin lymphoma (74.5%), Non-Hodgkin lymphoma (40.1%), CNS tumors (32.8%), renal tumors (58.4%), bone tumors (33.4%), retinoblastoma (59.2%), and other solid tumors (52.6%). The 3-year overall survival rates varied among the regions; children between the east and south-southeast had the higher risks (hazard ratio 3.0; 95% CI: 2.3–3.9) and 2.4; 95% CI: 2.0–2.8) of death from disease when compared with those from the central region. Conclusion. FPGC has increased coverage of cancer cases. Survival rates were different throughout the country. It is necessary to evaluate the effectiveness of this policy to increase access and identify opportunities to reduce the differences in survival. Pediatr Blood Cancer 2013;60:196– 203. 2012 Wiley Periodicals, Inc.
- Published
- 2012
- Full Text
- View/download PDF